|
EP1180158A1
(en)
*
|
1999-05-27 |
2002-02-20 |
Genovo, Incorporated |
Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
|
|
US6793926B1
(en)
*
|
1999-05-27 |
2004-09-21 |
Genovo, Inc. |
Methods for production of a recombinant adeno-associated virus
|
|
WO2000073424A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Mount Sinai School Of Medicine |
A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
|
|
GB9919409D0
(en)
|
1999-08-18 |
1999-10-20 |
Univ Oxford Brookes |
Baculovirus expression system
|
|
JP2006515162A
(ja)
|
2002-08-29 |
2006-05-25 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
環状核酸ベクター、ならびに同ベクターの作製法および使用法
|
|
GB0702694D0
(en)
*
|
2007-02-12 |
2007-03-21 |
Ark Therapeutics Ltd |
Vectors
|
|
GB0702695D0
(en)
*
|
2007-02-12 |
2007-03-21 |
Ark Therapeutics Ltd |
Production of vectors
|
|
EP2019143A1
(en)
|
2007-07-23 |
2009-01-28 |
Genethon |
CNS gene delivery using peripheral administration of AAV vectors
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
KR101575696B1
(ko)
*
|
2008-03-05 |
2015-12-08 |
카운실 오브 사이언티픽 엔드 인더스트리얼 리서치 |
고분자 하이브리드막
|
|
EP2287323A1
(en)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Widespread gene delivery to the retina using systemic administration of AAV vectors
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
WO2011123088A1
(en)
*
|
2010-04-01 |
2011-10-06 |
Weidong Xiao |
Compositions and methods for the production of recombinant virus vectors
|
|
JP2013523175A
(ja)
|
2010-04-14 |
2013-06-17 |
イーエムディー・ミリポア・コーポレーション |
高力価、高純度のウイルスストックの作製方法及びその使用方法
|
|
JP6385920B2
(ja)
|
2012-05-09 |
2018-09-05 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
アデノ随伴ウイルスプラスミド及びベクター
|
|
TWI775096B
(zh)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
US20150182637A1
(en)
|
2012-06-21 |
2015-07-02 |
Association Institut De Myologie |
Widespread gene delivery of gene therapy vectors
|
|
US11078464B2
(en)
*
|
2013-08-30 |
2021-08-03 |
Amgen Inc. |
High titer recombinant AAV vector production in adherent and suspension cells
|
|
CA2942776C
(en)
|
2014-03-17 |
2023-01-24 |
Adverum Biotechnologies, Inc. |
Polyneucleotide cassette and expression vector for expression of a gene in cone cells using truncated m-opsin promoter
|
|
KR20170137730A
(ko)
|
2015-03-02 |
2017-12-13 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
망막 추상체에 폴리뉴클레오타이드의 유리체 내 전달을 위한 조성물 및 방법
|
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
|
KR20200112811A
(ko)
|
2017-11-27 |
2020-10-05 |
코다 바이오테라퓨틱스 인코포레이티드 |
신경퇴행성 질환에 대한 조성물 및 방법
|
|
WO2019152843A1
(en)
|
2018-02-01 |
2019-08-08 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
|
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
|
US11306329B2
(en)
|
2018-02-19 |
2022-04-19 |
City Of Hope |
Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
|
|
EP3790979A4
(en)
|
2018-05-08 |
2022-04-27 |
Neuracle Science Co., Ltd |
RELEASE OF ADENO-ASSOCIATED VIRUS (AAV) FROM ANTI-FAM19A5 ANTIBODIES
|
|
KR20210130158A
(ko)
|
2019-01-31 |
2021-10-29 |
오레곤 헬스 앤드 사이언스 유니버시티 |
Aav 캡시드의 전사 의존적 유도 진화를 사용하는 방법
|
|
US20220348635A1
(en)
|
2019-08-21 |
2022-11-03 |
Coda Biotherapeutics, Inc. |
Compositions and methods for neurological diseases
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
IL301955A
(en)
|
2020-10-07 |
2023-06-01 |
Asklepios Biopharmaceutical Inc |
Therapeutic delivery of an adeno-related protein-related protein (FKRP) virus for the treatment of dystroglycanopathy disorders, including limb girdle 21
|
|
EP4514845A1
(en)
|
2022-04-29 |
2025-03-05 |
Broadwing Bio LLC |
Bispecific antibodies and methods of treating ocular disease
|
|
WO2023212293A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Complement factor h related 4-specific antibodies and uses thereof
|
|
WO2023212294A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Angiopoietin-related protein 7-specific antibodies and uses thereof
|
|
WO2024227154A1
(en)
|
2023-04-28 |
2024-10-31 |
Broadwing Bio Llc |
Complement component 3 (c3)-specific antibodies and uses thereof
|
|
WO2025040613A1
(en)
*
|
2023-08-21 |
2025-02-27 |
Vector Biopharma Ag |
Cell line for production of helper-dependent adenoviruses
|